Sanquin research into Covid-19 antibodies
Sanquin, in collaboration with Haagse Inkoop Samenwerking, is conducting scientific research into SARS‑CoV‑2 antibodies in blood donors. The study focuses on a representative group of healthy Dutch individuals, where blood collection and analysis take place within the framework of the Wet inzake Bloedvoorziening (Article 1, paragraph c1 and d). The objective is to obtain reliable data on the prevalence and duration of antibodies, which is of importance to public healthcare and vaccination policy. The procurement concerns a service contract in which Sanquin is responsible for the collection, processing, and analysis of blood samples, ensuring privacy and ethical standards, and reporting the results to the contracting authority. The procedure is a negotiated procedure without prior publication, whereby the selection of a suitable service provider based on expertise and experience is central.
Services · Onderhandeling zonder bekendmaking · National procedure
01What is being requested
Sanquin, in collaboration with Haagse Inkoop Samenwerking, is conducting scientific research into SARS‑CoV‑2 antibodies in blood donors. The study focuses on a representative group of healthy Dutch individuals, where blood collection and analysis take place within the framework of the Wet inzake Bloedvoorziening (Article 1, paragraph c1 and d). The objective is to obtain reliable data on the prevalence and duration of antibodies, which is of importance to public healthcare and vaccination policy. The procurement concerns a service contract in which Sanquin is responsible for the collection, processing, and analysis of blood samples, ensuring privacy and ethical standards, and reporting the results to the contracting authority. The procedure is a negotiated procedure without prior publication, whereby the selection of a suitable service provider based on expertise and experience is central.
Sanquin will conduct research into SARS-CoV-2 antibodies among their donors, as a representative group for the healthy Dutch population. According to the Wet inzake Bloedvoorziening Article 1, paragraph c1 and paragraph d, it is determined that Sanquin collects blood with the included purpose that scientific research is carried out.
02Outcome
Research & LabServices
03Value in context
04Bidders in this segment
05Legal themes that may be relevant here
06Frequently asked questions
What is the objective of the research into SARS-CoV-2 antibodies?
What is the legal basis for the blood collection by Sanquin?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 962K
€ 16 mln
€ 108 mln
Gegunde waarden in CPV 85 · diensten n=1531